You can buy or sell REXN and other stocks, options, ETFs, and crypto commission-free!
Rexahn Pharmaceuticals, Inc. Common Stock, also called Rexahn Pharmaceuticals, is a clinical stage biopharmaceutical company, which engages in the research and development of oncology therapeutics. Read More Its drug candidates include the following: RX-31171 for pancreatic, bladder, colon, and lung cancer; and RX-5902 for metastatic triple negative breast cancer. The company was founded by Chang Ho Ahn on March 19, 2001 and is headquartered in Rockville, MD. The listed name for REXN is Rexahn Pharmaceuticals, Inc. Common Stock.
52 Week High
52 Week Low
— per share
Expected Nov 4, Pre-Market